Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Apr-24 5:32 PM View:  | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 05-Apr-24 | Purchase | 37,712 | $4.74 | $178,755.00 | < 1% 9.24M to 9.28M | |
| 08-Apr-24 5:32 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 04-Apr-24 | Purchase | 140,281 | $4.67 | $655,112.00 | 2% 9.1M to 9.24M | |
| 03-Apr-24 5:22 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 03-Apr-24 | Purchase | 309,847 | $4.09 | $1,267,270.00 | 4% 8.79M to 9.1M | |
| 03-Apr-24 5:22 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 02-Apr-24 | Purchase | 186,051 | $3.44 | $640,015.00 | 2% 8.6M to 8.79M | |
| 03-Apr-24 5:22 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 01-Apr-24 | Private Purchase | 8,374 | $3.25 | $27,215.50 | < 1% 8.59M to 8.6M | |
| 12-Mar-24 8:04 PM View: | MacHatha Stephen Chief Development Officer | Aldeyra Therapeutics, Inc. (ALDX) | 12-Mar-24 | Sale | 11,537 | $3.16 | $36,503.10 | (5%) 255.24K to 243.71K | |
| 12-Mar-24 8:01 PM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 12-Mar-24 | Sale | 85,324 | $3.05 | $260,238.00 | (5%) 1.56M to 1.47M | |
| 12-Mar-24 8:04 PM View: | MacHatha Stephen Chief Development Officer | Aldeyra Therapeutics, Inc. (ALDX) | 11-Mar-24 | Market Sale | 18,231 | $3.41 | $62,102.10 | (7%) 273.47K to 255.24K | (13%) |
| 12-Mar-24 8:01 PM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 11-Mar-24 | Sale | 97,914 | $3.27 | $320,521.00 | (6%) 1.65M to 1.56M | |
| 12-Mar-24 8:07 PM View: | Greenberg Bruce See Remarks | Aldeyra Therapeutics, Inc. (ALDX) | 11-Mar-24 | Market Sale | 13,201 | $3.41 | $44,967.90 | (10%) 133.9K to 120.7K | (13%) |
| 18-Oct-23 5:15 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 18-Oct-23 | Sale | 306,499 | $1.74 | $533,308.00 | (3%) 8.9M to 8.59M | |
| 18-Oct-23 5:15 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 16-Oct-23 | Sale | 2,450,000 | $1.60 | $3,920,000.00 | (22%) 11.35M to 8.9M | |
| 11-Sep-23 4:31 PM View: | Phillips Gary M Director | Aldeyra Therapeutics, Inc. (ALDX) | 07-Sep-23 | Option Exercise | 5,437 | $0.55 | $3,001.22 | 58% 9.38K to 14.81K | |
| 11-Sep-23 5:42 PM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 07-Sep-23 | Payment of Exercise | 73,807 | $7.22 | $532,886.00 | (4%) 1.73M to 1.65M | |
| 11-Sep-23 5:42 PM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 07-Sep-23 | Option Exercise | 273,058 | $0.55 | $150,728.00 | 19% 1.46M to 1.73M | |
| 24-Aug-23 4:13 PM View: | Walker Neal Director | Aldeyra Therapeutics, Inc. (ALDX) | 22-Aug-23 | Option Exercise | 9,604 | $0.55 | $5,301.41 | 154% 6.25K to 15.85K | |
| 29-Jun-23 4:23 PM View: | Bronstein Ben Director | Aldeyra Therapeutics, Inc. (ALDX) | 27-Jun-23 | Option Exercise | 9,604 | $0.55 | $5,301.41 | 52% 18.64K to 28.25K | |
| 02-Mar-23 4:22 PM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 28-Feb-23 | Grant | 238,750 | -- | -- | 20% 1.22M to 1.46M | |
| 11-Aug-22 4:08 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 10-Aug-22 | Purchase | 15,000 | $7.85 | $117,750.00 | < 1% 11.34M to 11.35M | |
| 11-Aug-22 4:08 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 09-Aug-22 | Purchase | 100,000 | $7.50 | $750,000.00 | < 1% 11.24M to 11.34M | |
| 10-Aug-22 4:10 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 08-Aug-22 | Purchase | 97,000 | $7.24 | $702,280.00 | < 1% 11.14M to 11.24M | |
| 09-Aug-22 4:08 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 05-Aug-22 | Purchase | 141,000 | $6.95 | $979,950.00 | 1% 11.0M to 11.14M | |
| 08-Aug-22 4:09 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 04-Aug-22 | Purchase | 95,100 | $6.17 | $586,767.00 | < 1% 10.9M to 11.0M | |
| 05-Aug-22 4:10 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 03-Aug-22 | Purchase | 100,000 | $5.84 | $584,000.00 | < 1% 10.8M to 10.9M | |
| 04-Aug-22 4:10 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 02-Aug-22 | Purchase | 412,406 | $5.59 | $2,305,350.00 | 4% 10.39M to 10.8M | |
| 03-Aug-22 5:16 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 01-Aug-22 | Purchase | 144,185 | $5.05 | $728,134.00 | 1% 10.25M to 10.39M | |
| 02-Aug-22 4:27 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 29-Jul-22 | Purchase | 222,123 | $5.03 | $1,117,280.00 | 2% 10.02M to 10.25M | |
| 01-Aug-22 5:37 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 28-Jul-22 | Purchase | 119,392 | $5.00 | $596,960.00 | 1% 9.9M to 10.02M | |
| 19-Jul-22 4:34 PM View: | MacHatha Stephen Chief Development Officer | Aldeyra Therapeutics, Inc. (ALDX) | 15-Jul-22 | Grant | 185,605 | -- | -- | 211% 87.87K to 273.47K | |
| 19-Jul-22 4:34 PM View: | Greenberg Bruce See Remarks | Aldeyra Therapeutics, Inc. (ALDX) | 15-Jul-22 | Grant | 126,087 | -- | -- | 1614% 7.81K to 133.9K | |
| 27-Jun-22 6:41 AM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 23-Jun-22 | Private Purchase | 17,700 | $3.36 | $59,546.30 | 1% 1.2M to 1.22M | |
| 27-Jun-22 6:42 AM View: | Joyce Martin Joseph Director | Aldeyra Therapeutics, Inc. (ALDX) | 23-Jun-22 | Market Purchase | 4,323 | $3.48 | $15,024.60 | 22% 19.64K to 23.97K | 10% |
| 01-Apr-22 7:37 PM View: | MacHatha Stephen Chief Development Officer | Aldeyra Therapeutics, Inc. (ALDX) | 30-Mar-22 | Grant | 64,395 | -- | -- | 274% 23.47K to 87.87K | |
| 01-Apr-22 7:44 PM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 30-Mar-22 | Grant | 250,000 | -- | -- | 26% 948.84K to 1.2M | |
| 01-Apr-22 7:37 PM View: | Reed Joshua Chief Financial Officer | Aldeyra Therapeutics, Inc. (ALDX) | 30-Mar-22 | Grant | 93,322 | -- | -- | 51% 181.5K to 274.82K | |
| 04-May-21 5:55 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 03-May-21 | Market Purchase | 1,200,000 | $12.50 | $15,000,000.00 | 14% 8.7M to 9.9M | (< 1%) |
| 14-Apr-21 7:23 PM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 12-Apr-21 | Grant | 46,619 | -- | -- | 5% 902.22K to 948.84K | |
| 21-Jan-21 5:24 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 19-Jan-21 | Private Purchase | 1,368,420 | $9.50 | $13,000,000.00 | 19% 7.34M to 8.7M | |
| 11-Jan-21 9:53 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 08-Jan-21 | Market Purchase | 550,000 | $9.34 | $5,137,670.00 | 8% 6.79M to 7.34M | 10% |
| 11-Jan-21 9:53 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 07-Jan-21 | Market Purchase | 500,000 | $8.13 | $4,065,000.00 | 8% 6.29M to 6.79M | 27% |
| 13-Jul-20 4:30 PM View: | Perceptive Advisors LLC 10% Owner | Aldeyra Therapeutics, Inc. (ALDX) | 09-Jul-20 | Market Purchase | 3,200,000 | $4.25 | $13,600,000.00 | 104% 3.09M to 6.29M | 77% |
| 17-Mar-20 4:38 PM View: | Douglas Richard Director | Aldeyra Therapeutics, Inc. (ALDX) | 16-Mar-20 | Market Purchase | 40,000 | $2.75 | $110,000.00 | 47% 85.0K to 125.0K | 173% |
| 04-Mar-20 7:44 PM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 02-Mar-20 | Grant | 250,000 | -- | -- | 38% 652.22K to 902.22K | |
| 04-Mar-20 7:49 PM View: | Reed Joshua Chief Financial Officer | Aldeyra Therapeutics, Inc. (ALDX) | 02-Mar-20 | Grant | 250,000 | -- | -- | 699% 35.77K to 285.77K | |
| 04-Mar-20 7:46 PM View: | McMullin David Chief Commercial Officer | Aldeyra Therapeutics, Inc. (ALDX) | 02-Mar-20 | Grant | 250,000 | -- | -- | 3245% 7.7K to 257.7K | |
| 18-Dec-19 7:35 AM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 16-Dec-19 | Market Purchase | 20,000 | $5.10 | $101,908.00 | 3% 632.22K to 652.22K | 47% |
| 02-Oct-19 7:36 AM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 30-Sep-19 | Market Purchase (Planned) | 8,710 | $5.68 | $49,483.30 | 1% 623.51K to 632.22K | 32% |
| 25-Sep-19 7:40 AM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 23-Sep-19 | Market Purchase (Planned) | 8,680 | $5.81 | $50,432.50 | 1% 614.83K to 623.51K | 29% |
| 20-Sep-19 7:37 AM View: | Brady Todd C President and CEO Director | Aldeyra Therapeutics, Inc. (ALDX) | 18-Sep-19 | Market Purchase | 14,288 | $5.91 | $84,464.90 | 2% 600.54K to 614.83K | 27% |
| 19-Sep-19 4:23 PM View: | Bronstein Ben Director | Aldeyra Therapeutics, Inc. (ALDX) | 17-Sep-19 | Market Purchase | 1,700 | $5.85 | $9,945.00 | 10% 16.94K to 18.64K | 28% |
